Obesity: is it really a risk factor in thrombophlebitis?

Area of Science:

• Bariatric Surgery
• Vascular Surgery
• Thromboembolism Research

Background:

• Obesity is widely considered a risk factor for thrombophlebitis.
• Gastric bypass surgery is a common bariatric procedure for individuals with extreme obesity.
• The actual incidence of deep vein thrombophlebitis (DVT) and thromboembolism in this patient population requires further investigation.

Purpose of the Study:

• To evaluate the incidence of postoperative deep vein thrombophlebitis and thromboembolism in patients undergoing gastric bypass surgery for extreme obesity.
• To determine if extreme obesity is a significant risk factor for these complications in the context of bariatric surgery.
• To assess the necessity and risk-benefit ratio of prophylactic anticoagulant therapy in this patient group.

Main Methods:

• Retrospective study of 168 consecutive gastric bypass patients (33 male, 135 female; average age 34).
• Preoperative noninvasive vascular studies (Doppler, IPG, PRG) were performed on 84 patients.
• Postoperative complications, including thromboembolism confirmed by imaging (V/Q scan, pulmonary angiogram), were meticulously recorded.

Main Results:

• The incidence of clinical deep vein thrombophlebitis was zero.
• Noninvasive evaluation showed no abnormalities in 64 patients.
• Postoperative thromboembolism occurred in 3 out of 168 patients (1.8%), with one mortality (<1%).

Conclusions:

• Extreme obesity alone may not be a major risk factor for postoperative deep vein thrombophlebitis and thromboembolism after gastric bypass.
• The risks associated with prophylactic medications and therapies must be carefully weighed against the low incidence of thromboembolism and mortality.
• Current prophylactic strategies may introduce unnecessary risks, costs, and discomfort for patients undergoing gastric bypass for obesity.